Rapid Micro Biosystems, Inc. (RPID) stock
RPIDNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 7/3050% below fair value
$0.74−0.00 (-0.43%)
Close on Nov 17, 2026Market cap $36.96MP/E –Yield –
Rapid Micro Biosystems operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Rapid Micro Biosystems's operating cash flow for the twelve months ending Jun 30, 2026 was -$40.06M. For fiscal 2025 it was -$31.06M. The highest annual figure on record is -$31.00M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$31.06M | – |
| FY2024 | Dec 31, 2024 | -$44.15M | – |
| FY2023 | Dec 31, 2023 | -$45.08M | – |
| FY2022 | Dec 31, 2022 | -$58.55M | – |
| FY2021 | Dec 31, 2021 | -$54.96M | – |
| FY2020 | Dec 31, 2020 | -$31.00M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$12.70M | – |
| Q1 FY2026 | Mar 31, 2026 | -$15.06M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.25M | – |
| Q3 FY2025 | Sep 30, 2025 | -$9.05M | – |
| Q2 FY2025 | Jun 30, 2025 | -$9.70M | – |
| Q1 FY2025 | Mar 31, 2025 | -$9.07M | – |
| Q4 FY2024 | Dec 31, 2024 | -$9.91M | – |
| Q3 FY2024 | Sep 30, 2024 | -$8.60M | – |
| Q2 FY2024 | Jun 30, 2024 | -$10.12M | – |
| Q1 FY2024 | Mar 31, 2024 | -$15.53M | – |
| Q4 FY2023 | Dec 31, 2023 | -$9.50M | – |
| Q3 FY2023 | Sep 30, 2023 | -$9.71M | – |
| Q2 FY2023 | Jun 30, 2023 | -$9.19M | – |
| Q1 FY2023 | Mar 31, 2023 | -$16.69M | – |
| Q4 FY2022 | Dec 31, 2022 | -$11.66M | – |
| Q3 FY2022 | Sep 30, 2022 | -$15.11M | – |
| Q2 FY2022 | Jun 30, 2022 | -$14.99M | – |
| Q1 FY2022 | Mar 31, 2022 | -$16.80M | – |
| Q4 FY2021 | Dec 31, 2021 | -$12.89M | – |
| Q3 FY2021 | Sep 30, 2021 | -$19.31M | – |
| Q2 FY2021 | Jun 30, 2021 | -$11.51M | – |
| Q1 FY2021 | Mar 31, 2021 | -$11.26M | – |
| Q4 FY2020 | Dec 31, 2020 | -$5.17M | – |
| Q3 FY2020 | Sep 30, 2020 | -$8.82M | – |
See a number that looks wrong?